Attitudes toward long-acting injectable antipsychotics among patients with schizophrenia in Japan
Norio Sugawara,1,2 Shuhei Kudo,2 Masamichi Ishioka,3 Yasushi Sato,2,4 Kazutoshi Kubo,3 Norio Yasui-Furukori2 1Department of Clinical Epidemiology, Translational Medical Center, National Center of Neurology and Psychiatry, Kodaira, Japan; 2Department of Neuropsychiatry, Hirosaki University School of...
Main Authors: | Sugawara N, Kudo S, Ishioka M, Sato Y, Kubo K, Yasui-Furukori N |
---|---|
Format: | Article |
Language: | English |
Published: |
Dove Medical Press
2019-01-01
|
Series: | Neuropsychiatric Disease and Treatment |
Subjects: | |
Online Access: | https://www.dovepress.com/attitudes-toward-long-acting-injectable-antipsychotics-among-patients--peer-reviewed-article-NDT |
Similar Items
-
Clinical Decision-Making in the Treatment of Schizophrenia: Focus on Long-Acting Injectable Antipsychotics
by: Ludovic Samalin, et al.
Published: (2016-11-01) -
Initiating long-acting injectable antipsychotics during acute admission for patients with schizophrenia – A 3-year follow-up
by: Chen-Chung Liu, et al.
Published: (2015-06-01) -
Effectiveness of Long-Acting Injectable Antipsychotics in Schizophrenia: A Literature Review and Bayesian Meta-Analysis Informing Economic Considerations
by: Orietta Zaniolo, et al.
Published: (2019-02-01) -
Second-generation long-acting injectable antipsychotics in schizophrenia: patient functioning and quality of life
by: Montemagni C, et al.
Published: (2016-04-01) -
Comparative Effectiveness of Second Generation Long-acting Injectable Antipsychotics Based on Nationwide Database Research in Hungary: An Update
by: Balázs, T., et al.
Published: (2022)